Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 07, 2023

SELL
$3.75 - $20.05 $30,937 - $165,412
-8,250 Reduced 37.08%
14,000 $264,000
Q1 2021

May 14, 2021

SELL
$6.5 - $10.53 $6,500 - $10,530
-1,000 Reduced 4.3%
22,250 $180,000
Q4 2019

Feb 12, 2020

BUY
$2.25 - $5.8 $52,312 - $134,850
23,250 New
23,250 $119,000

Others Institutions Holding IMGN

About ImmunoGen, Inc.


  • Ticker IMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 220,712,992
  • Description
  • ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...
More about IMGN
Track This Portfolio

Track Mine & Arao Wealth Creation & Management, Llc. Portfolio

Follow Mine & Arao Wealth Creation & Management, Llc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mine & Arao Wealth Creation & Management, Llc., based on Form 13F filings with the SEC.

News

Stay updated on Mine & Arao Wealth Creation & Management, Llc. with notifications on news.